AbbVie的股票在内幕出售后下跌,但该公司更新了指南,提高了股息。 AbbVie's stock dipped after an insider sale, but the company updated its guidance and raised its dividend.

AbbVie的股价在4月2日下降0.2%, AbbVie's stock fell 0.2% on April 2 after an insider sold shares, but the company maintains a "Moderate Buy" rating and a target price of $211.45. 尽管缺少Q1收入估计数,但AbbVie更新了2025年指南,报告净差率为7.59%。 Despite missing Q1 earnings estimates, AbbVie updated its 2025 guidance and reported a net margin of 7.59%. 该公司还宣布季度股利为每股1.64美元,定于5月15日支付。 The company also declared a quarterly dividend of $1.64 per share, set to be paid on May 15th. 分析家提高了价格目标,有些分析家给予股票“强购”评级。 Analysts have raised price targets, with some giving the stock a "strong-buy" rating.